ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACSO Accesso Technology Group Plc

536.00
5.00 (0.94%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Accesso Technology Group Plc LSE:ACSO London Ordinary Share GB0001771426 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.94% 536.00 531.00 536.00 536.00 531.00 535.00 28,939 16:25:32
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Cmp Integrated Sys Design 139.73M 10.06M 0.2395 22.38 225.08M
Accesso Technology Group Plc is listed in the Cmp Integrated Sys Design sector of the London Stock Exchange with ticker ACSO. The last closing price for Accesso Technology was 531p. Over the last year, Accesso Technology shares have traded in a share price range of 500.00p to 822.00p.

Accesso Technology currently has 41,993,464 shares in issue. The market capitalisation of Accesso Technology is £225.08 million. Accesso Technology has a price to earnings ratio (PE ratio) of 22.38.

Accesso Technology Share Discussion Threads

Showing 3101 to 3125 of 5375 messages
Chat Pages: Latest  131  130  129  128  127  126  125  124  123  122  121  120  Older
DateSubjectAuthorDiscuss
12/11/2018
11:49
It is surprising the company haven't really come out and comment on the share price piece at least. Before that came out it was probably difficult to say no reason for drop. Now they can reference the piece and try to rebut it. Could be argued they should try and avoid a slanging match but equally long term holders getting creamed need protecting as well. Interesting that TT are getting even more aggressive even as it falls. Opposite of what should really be happening as the very easy gains have probably been made for now.
horndean eagle
12/11/2018
08:20
Not negative, just realistic! Even the most hardened investor and supporter of a company has to take capital preservation measures at some point.Let's hope it doesn't come to that.spud
spud
12/11/2018
07:50
Wednesday, accesso is holding a press event at the 2018 IAAPA Attractions Expo. If they have anything new product-wise up their sleeve, or they win another one of the industry awards, this week and this trade show is when we would hear about it.
1001011
12/11/2018
07:28
that's very negative spud - unlike you. what has made you change your mind?
janeann
12/11/2018
07:25
We are now just above the placing price of £16.20 on 13-Jul-17 relating to the purchase of TE2.
shanklin
11/11/2018
16:32
The Market will need reassurance at some point regardless unless the Company is happy to have a run on the price. We’re seeing zero support from IIs atm and without it, this could very easily slip below £10. If that happens even I will have to re-evaluate my position here...

spud

spud
11/11/2018
16:14
If there is any bad business/trading news, the company would be obliged to rns it anyway. An absence of a statement can therefore be read as good news. There is also the risk that a ‘reassuring217; statement could be misinterpreted or dismissed as ‘they would say that anyway’, so just as well to stay quiet and let the next results be analysed then.
aimingupward2
11/11/2018
15:50
Indeed - An increase from 0.7% to 0.86%. My guess is they'll continue to increase their Short position until the price is such that the Company is forced to issue a statement. A drop of 50% + within 4 week timeframe (below £15) should trigger that imo. spud
spud
11/11/2018
11:24
As of 6th Nov, TT International had a short position of 0.86%
hxxps://shorttracker.co.uk/company/GB0001771426/

chasbas
10/11/2018
18:36
FWIW An analysis of the trading on Friday
'
Data uses total of all deals made with no difference between buys or sells. If you assumes each dealt was either a discrete buy or sell divided by 2 to get number of shares changing hands.
'
Deals Grouped by bands of shares traded
'
Band___________Num Deals_____Value________Average___Weighted
by number of shares
'
Up to 500 NMS______101______£313,598________£3,105_____3%
>500 <=1,500________27______£423,681_______£15,692_____5%
>1,500 <=5,000______20____£1,037,655_______£51,883____11%
>5,000 <=10,000_____13____£1,783,420______£137,186____19%
>10,000 <=50,000_____8____£3,338,738______£417,342____36%
Over 50,000__________2____£2,320,961____£1,160,480____25%
===========================================================
Total _____________171____£9,218,052____________Errors and Omission excepted
Cancelled____________8
'
Roughly a quarter of the deals in the highest 4 bands accounted for some 98 % of the total value. Highest band with two entries has some 25% of total value.
'
Private Investors normally trade around Normal market size NMS or 500.
'
IMHO___Volatility of this thinly traded share was created by just a handful of large active traders.


Append
Above table show discrete deals but a number of probable day trades are noted. The most notable being a confident £1.1 million trade late in the day.

Date/Time______________Price____Shares_____Value
15:55:25 09-Nov-2018 1,650.00 GBX 70,297 1,159,900.50
16:08:37 09-Nov-2018 1,651.65 GBX 70,297 1,161,060.40

Thirteen minutes and enough gross to pay for a hospitality ticket to the All Blacks game at Twickenham.

togglebrush
10/11/2018
10:51
17%, 47%, 11%, or 4%... which number are you going to pick? Good luck.
skatersav
10/11/2018
10:36
In the interims they state that stripping out the acquisitions:

“ Underlying like for like growth, on a consistent IFRS 15 basis, was approximately 11%.”

Why is that dishonest?

wjccghcc
10/11/2018
10:01
My post was aimed at the claim of dishonest in the ShareProphets article. Let’s get things straight. Management made a massive brouhaha about their “47% underlying growth” at the recent results, but this “overlooked221; the two massive acquisitions it had made in the interim. The ShareProphets article corrects for that and presents an estimate of pro forma growth. This compares the current combined businesses with their combined performance in H1 17. In other words seasonally adjusted true organic growth! There is dishonesty in this story somewhere...
skatersav
10/11/2018
09:56
Wrong! The H1 revenue number is compared against the H1 2017 revenue number - this removes seasonality.
skatersav
10/11/2018
09:23
Isnt the bigger point to take operational cash flow from the last 5 years, say that capex is excessive because of investment for growth, and therefore make adjustments to it (haircut by 50% is easy enough).

Issue is that you take this normalised free cash flow number and the stock still looks expensive. And that's what determines business value. Do you really see investment going down over the next 5 years? Ive tried a DCF

Also, lets not forget that this growth is not organic. Theyve bought a substantial chunk of it

dan_the_epic
10/11/2018
08:06
Think you've nailed it itchy - Pretty much the way I view it. And although you could argue that I really don't really need any more stock, it's a function of a successful investor to accumulate more wealth as a reflection of his investment strategy and ultimate success.spud
spud
10/11/2018
06:18
The hangman there's a blast from the past ...he was arguing this overvalued at 30p....8 or 9 years ago?
sonofbanjosinger
10/11/2018
00:39
The fundamental oversight(/dishonesty?) of all these Shareprophets calculations is that the author focuses in on H1 growth of a largely SEASONAL! business.

In the theme park industry, July, August, and Halloween (all in H2) are when the big cash rolls in and when off-season investments pay off. H1 growth, be it revenue or cash flow, is supposed to lag full-year growth expectations, by design, for an H2-heavy seasonal business. The off-season and low-season aren't meaningful predictors of peak season growth.

1001011
09/11/2018
23:31
Accesso has created a portfolio of solutions that has gained widespread traction and has opened up huge opportunities in other areas that were originally not even target sectors. As a result, and to capitalise on the growth in these areas, Accesso (and quite rightly so), is investing heavily in its future growth. It's just the normal function of a company undergoing a period or rapid growth.

If ever there was a buy and hold stock then Accesso is it. Unless you really understand the business and the management it's easy to adopt a 'traders mentality'. For me, the drop in the share price represents an unbelievable opportunity to add at levels I never expected to see again, especially with the low liquidity (which has largely exaggerated this drop in the share price). Building a large holding has always been difficult due to the low float and low liquidity.
I have been and will continue to drip-buy on an ongoing basis.

itchycrack
09/11/2018
19:15
I've read the Shareprophets article. They make some compelling points around free cash flow. Can they really turn off that spending tap? On a free cash flow basis, the stock is very weak, so the big question is what is normalised free cash flow and then value Accesso on a 4% free cash flow yield off that. At the moment, that answer is quite negative on my numbers
dan_the_epic
09/11/2018
19:15
He was certainly here early days along with Glenn who sold at just over a quid to buy a load of property. I suppose I shouldn’t̵7;t grumble. Similar time I bought Sprue and made over 500k in them.
the big fella
09/11/2018
17:43
Never did buy the percy 350k - Especially when he inadvertently let slip a comment about his boss when the shares were @ circa £8.

Probably bought 3k’s worth, had a few pints and got carried away late night on the keyboard.

Sceptical spud

spud
09/11/2018
15:01
Just looking at ACSO's tweets and think this job in the "healthcare vertical" sounds quite interesting in terms of what ACSO are seeking to achieve.

401K, Medical
Employment Type
Full-Time
Why Work Here?

“Innovative technology company servicing clients in the attractions industry, awesome work culture, rapidly growing with generous benefits!”

About Us

accesso® is a worldwide software company delivering industry-leading virtual queuing, eCommerce, ticketing, and experience management solutions for a wide range of industries, including attractions, hospitality, healthcare, cultural, leisure and quick-service food. Our products and services already support some of the top venues in the world including a wide variety of paid admission operations in household name attractions, ranging from theme parks, water parks and zoos to cultural attractions, cruise ships and sporting events. Our innovative approach to driving revenue is a key differentiator of our proprietary and patented technology. We help our clients achieve their goals through our unsurpassed service, rapid-release software deployment and commitment to innovation. Everything we do helps our clients focus on what they do best - providing outstanding experiences for guests - while we provide technology that readily supports our clients’ efforts to drive revenue. We have focused intensely on fine tuning our process to ensure success for our clients and our company.

Position Overview

The Senior Product Manager for accesso's healthcare vertical is responsible for all product management related functions for CareReady. CareReady combines the software of TE2 with the wearable technology of accesso LoQueue. This role will work with other product teams to bring the CareReady MVP to market. The goal for the CareReady solution is to transform the patient experience by eliminating the communication gaps in a hospital setting, while assisting healthcare providers to undercover operational inefficiencies and opportunities to elevate their HCAHPS scores.

The CareReady Senior Product Manager will meet with current and future customers, develop and own the backlog, prove out product market fit, and work closely with partners (internal and external) to develop the CareReady product roadmap, drive software releases, and support customer launches. The CareReady Senior Product Manager will use a dual-track agile product discovery process to rapidly introduce new capabilities. You will be working closely with other Product Management teams, Business Development, UX, and Engineering.

Reports To: President, TE2 (interim)

Location: Lake Mary, FL

Travel: Up to 50% to internal and external meetings.

Key Responsibilities and Deliverables

Assess product opportunities within the healthcare space and validate decisions with clients and users.
Define, test and prove what product and features are to be prioritized and built.
Leverage tools and techniques that are customary for the product management function.
Define MVP and new features, write user stories and acceptance criteria, define KPIs, set OKRs, own and prioritize backlog, and triage defects to iteratively deliver, launch, and measure the success of each release.
Create and manage the product roadmap for CareReady, insuring your team is always working on the highest priority functionality.
Identify opportunities for new features and develop business and product plans and success metrics to make the case for investment.
Set quantifiable goals with customers to increase their HCAHPS scores.
Work closely with cross-functional accesso stakeholders to understand current and future requirements for CareReady, while also understanding the market landscape of available solutions.
Build trusted and valuable relationships, supported by great communication skills with the engineering, quality, and project management and scrum teams to ensure a successful and coordinated product development process, including working through development dependencies.
Attend and present at customer meetings, internal company functions, and healthcare conferences to aid business development.
Ensure product and services are aligned to customer needs.
Ensure we communicate product releases through presentations and authoring of customer release notes and documentation in conjunction with technical writers.
Support the scrum team in designing platform functionality, reviewing design documents and architecture, and participating in technical discussions.
Conduct candidate interviews and help scale the healthcare vertical at accesso.

Work with Business Development to:

Create a comprehensive vision and annual sales strategy, focused on gross margin and profitability.
Continually gather and analyze market data and industry trends within healthcare vertical.
Present objective data for build vs. buy decisions relating to bringing CareReady to market.
Develop a comprehensive understanding of the competitive landscape.
Create and refine value messaging for the CareReady product.

Experience & Requirements

7+ years of product management experience, with a minimum of 3 years of experience within the healthcare space.
4+ years of customer facing product and/or business development experience.
BS Degree or equivalent work experience.
Experience conducting product discovery testing.
Experience establishing goals and metrics to measure effectiveness after releases; monitor & report on progress.
Ability to analyze potential partner relationships.
Strong team skills, both as a leader of a product team but also working across product teams to get the best results for the company.
Ability to converse fluently engineers about technology as well as executives and customers about business needs and objectives.

What We Offer

Competitive salary based on experience
The opportunity to earn an annual company discretionary bonus with the potential for stock options
Generous Paid Time Off as well as paid Volunteer Time Off
Health insurance plans, including employer-contributed HSA and employer-paid disability and life insurance.
Matching 401K
Unlimited access to Udemy for Business for continued learning and career development
A flexible work schedule around our core business hours

Other Considerations

We are an E-Verify organization. Eligible candidates must be authorized to work in the US without requiring visa sponsorship.
accesso is a drug free and smoke free company, meaning employees may not smoke or use illegal drugs while at work or away from work.
This is a full-time position. No contractors please.

If you are interested in joining a team who values Passion, Commitment, Teamwork, Innovation and Integrity and what we’ve described above is YOU, then apply today and let’s talk!
accesso Technology Group, plc
About accesso Technology Group, plc:

accesso technology has been providing cutting edge queuing and ticketing solutions to major theme parks and attractions for over a decade. Our powerful and innovative solutions deliver breakthrough revenue generating technology for our clients around the world. Our products and services currently support some of the top attractions in the world including a wide variety of paid admission operations ranging from theme parks, water parks and zoos to cultural attractions and sporting events.

Our innovative approach to driving revenue are key differentiators of our proprietary and patented technology. We help our clients achieve their goals through our unsurpassed service, rapid release software deployment and commitment to innovation. Everything we do helps our clients focus on what they do best, providing outstanding experiences for guests while we provide technology that readily supports our clients efforts to drive revenue. We have focused intensely on fine tuning our process to ensure success for our clients and, in turn, our company.

Company website:

Company address: 1025 Greenwood Blvd #500, Lake Mary, FL 32746

shanklin
09/11/2018
12:27
Morning Hangers. This was the one that well and truelly got away for me. 250k shares at under 10p nearly all sold before £1. Hey ho.
the big fella
09/11/2018
11:58
Dear me,i'm no chartist but Just look at the chart.., looking like another big spike downwards, just hope this does not turn into another CRAW, but those unlucky shareholders, did get a couple of dividends, Morning BF, hope you are keeping well
mr hangman
Chat Pages: Latest  131  130  129  128  127  126  125  124  123  122  121  120  Older

Your Recent History

Delayed Upgrade Clock